Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Challenges in estimating waning effectiveness of two doses of BNT162b2 and ChAdOx1 COVID-19 vaccines beyond six months: an OpenSAFELY cohort study using linked electronic health records.
Horne, EM F; Hulme, W; KEOGH, R; Palmer, T; WILLIAMSON, E; PARKER, EP K; Walker, V; Knight, R; Wei, Y; Taylor, K; Fisher, L; Morley, J; Mehrkar, A; Dillingham, I; Bacon, S; GOLDACRE, B; Sterne, JA C; The OpenSAFELY Collaborative,;
2023
medRxiv (2023). 10.1101/2023.01.04.22283762.
Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis.
Ciapponi, A; Berrueta, M; Ballivian, J; Bardach, A; Mazzoni, A; Anderson, S; Argento, FJ; Bok, K; Comandé, D; Goucher, E; KAMPMANN, B; PARKER, EP K; Rodriguez-Cairoli, F; Santa Maria, V; Stergachis, A; Voss, G; Xiong, X; Zaraa, S; Munoz, FM; Karron, RA; Gottlieb, SL; Buekens, PM;
2023
Medicine, (2023).102 9 10.1097/MD.0000000000032954.
Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study.
Mwenda, V; Jalang'o, R; Miano, C; Bor, J-P; Nyangasi, M; Mecca, L; Were, V; Kariithi, E; Pecenka, C; Schuind, A; ABBAS, K; CLARK, A;
2023
Vaccine, (2023).41 29 10.1016/j.vaccine.2023.05.019.
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP.
Hulme, WJ; Horne, EM F; PARKER, EP K; KEOGH, RH; WILLIAMSON, EJ; Walker, V; Palmer, TM; Curtis, HJ; Walker, AJ; Andrews, CD; Mehrkar, A; Morley, J; MacKenna, B; Bacon, SC J; GOLDACRE, B; Hernán, MA; Sterne, JA C;
2023
BMJ, (2023).380, 10.1136/bmj-2022-072808.
Modeling the potential health impact of prospective Strep A vaccines.
Giannini, F; Cannon, JW; Cadarette, D; Bloom, DE; Moore, HC; Carapetis, J; ABBAS, K;
2023
NPJ vaccines, (2023).8 1 10.1038/s41541-023-00668-0.
Association Between Maternal Breastmilk Microbiota Composition and Rotavirus Vaccine Response in African, Asian, and European Infants: A Prospective Cohort Study.
Mandolo, J; PARKER, EP K; Bronowski, C; Sindhu, KN C; Darby, AC; Cunliffe, NA; Kang, G; Iturriza-Gómara, M; Kamng'ona, AW; Jere, KC;
2023
Journal of infectious diseases, (2023).228 5 10.1093/infdis/jiad234.
Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study.
KIM, C; Holm, M; Frost, I; Hasso-Agopsowicz, M; ABBAS, K;
2023
BMJ global health, (2023).8 7 10.1136/bmjgh-2022-011341.
CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLAND.
Horne, EM F; Hulme, WJ; KEOGH, RH; Palmer, TM; WILLIAMSON, EJ; PARKER, EP K; Walker, VM; Knight, R; Wei, Y; Taylor, K; Fisher, L; Morley, J; Mehrkar, A; Dillingham, I; Bacon, S; GOLDACRE, B; Sterne, JA C; OpenSAFELY Collaborative, FT;
2023
American journal of epidemiology, (2023).193 1 10.1093/aje/kwad179.
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
AUZENBERGS, M; FU, H; ABBAS, K; PROCTER, SR; Cutts, FT; JIT, M;
2023
The Lancet. Global health, (2023).11 8 10.1016/S2214-109X(23)00220-6.
Effect of the 2022 COVID-19 booster vaccination campaign in 50 year olds in England: regression discontinuity analysis in OpenSAFELY.
Schaffer, A; Hulme, W; Horne, E; PARKER, E; Walker, V; Stables, C; Mehrkar, A; Bacon, SC J; Bates, C; GOLDACRE, B; Walker, A; Hernán, M; Sterne, J; The OpenSAFELY Collaborative,;
2023
medRxiv (2023). 10.1101/2023.09.07.23295194.